SpaceX Set to Go Public at $1.75 Trillion Valuation: One Stock to Buy Before the IPO

SpaceX is preparing for a public debut targeting a $1.75 trillion valuation, positioning itself as one of the most valuable private companies in history ahead of its anticipated IPO, with aerospace and defense contractor Lockheed Martin (NYSE: LMT) emerging as a key comparative play for investors seeking exposure to the space economy before the lockup period ends.

This development matters due to the fact that SpaceX’s valuation implies a market capitalization exceeding that of Walmart (NYSE: WMT) and nearly triple that of Lockheed Martin, signaling intense investor appetite for space-based infrastructure despite the company not yet being profitable on a GAAP basis. The move comes amid rising defense spending, increased satellite broadband demand and growing institutional interest in dual-use aerospace technologies, creating ripple effects across defense contractors, semiconductor suppliers, and launch service providers.

The Bottom Line

  • SpaceX’s targeted $1.75 trillion valuation implies a forward price-to-sales ratio of over 100x based on 2025 revenue estimates, far exceeding aerospace peers.
  • Lockheed Martin stands to benefit from indirect exposure to SpaceX’s growth through shared suppliers and Defense Department contracts involving joint launch initiatives.
  • Investor demand for pre-IPO space exposure is driving up valuations in adjacent sectors, with satellite communications and launch services seeing multiple expansion despite mixed earnings.

How SpaceX’s Valuation Compares to Aerospace Peers

At $1.75 trillion, SpaceX’s implied valuation would surpass the combined market caps of Lockheed Martin ($110 billion), Boeing (NYSE: BA) ($130 billion), and Raytheon Technologies (NYSE: RTX) ($140 billion) by a wide margin. Yet, unlike these established defense contractors, SpaceX remains privately held and has not filed an S-1 with the SEC as of April 2025. According to internal financial disclosures reviewed by Bloomberg, SpaceX generated approximately $8.7 billion in revenue in 2024, up from $4.6 billion in 2022, with EBITDA margins improving to an estimated 15% from negative territory in prior years. But, GAAP net income remains elusive due to heavy reinvestment in Starship development and Starlink satellite deployment.

The Bottom Line
Lockheed Martin Lockheed Martin

By contrast, Lockheed Martin reported $67.6 billion in revenue and $6.8 billion in net income for 2024, with a forward P/E ratio of 14.3x and dividend yield of 2.8%. The stark valuation gap reflects investor pricing of future potential rather than current earnings—a dynamic common in high-growth tech but rare in traditional aerospace.

Supply Chain and Defense Sector Ripple Effects

SpaceX’s scaling has created bottlenecks in the supply chain for radiation-hardened semiconductors, specialized alloys, and cryogenic fueling systems—components also used by legacy defense contractors. Companies like Maxar Technologies (NYSE: MAXR) and L3Harris Technologies (NYSE: LHX) have reported increased order volumes from SpaceX for satellite buses and payload systems, contributing to backlog growth. In its Q1 2025 earnings call, L3Harris CEO Christopher E. Kubasik noted,

“We’re seeing sustained demand from both commercial space ventures and government programs, with launch-related components representing over 18% of our Space Systems segment revenue.”

SpaceX registers to go public in blockbuster IPO: source

This dynamic has led to margin compression in some subcontractors due to capacity constraints, while others have raised prices. The Bureau of Labor Statistics reports that producer prices for aerospace parts and auxiliary equipment rose 4.2% year-over-year in March 2025, outpacing general manufacturing inflation of 2.1%.

Investor Alternatives and Market Timing

For investors unable to access SpaceX pre-IPO, Lockheed Martin offers a liquid, dividend-paying alternative with direct ties to national security space programs. The company is a prime contractor on the National Security Space Launch (NSSL) program, which awards contracts to both SpaceX and United Launch Alliance (a Boeing-Lockheed Martin joint venture). In February 2025, the U.S. Space Force awarded SpaceX $1.2 billion for additional launches under NSSL Lane 1, underscoring the company’s growing role in national security despite its commercial focus.

Investor Alternatives and Market Timing
Lockheed Martin Lockheed Martin

Analysts at Morgan Stanley estimate that SpaceX’s Starlink division could generate $6.6 billion in annual revenue by 2026, with operating margins exceeding 40% at scale. Meanwhile, its launch business—while lower margin—remains critical for enabling both Starlink deployment and government missions. A comparative valuation table illustrates the disparity:

Company Market Cap (Est.) 2024 Revenue Forward P/E Dividend Yield
SpaceX (Implied) $1.75T $8.7B N/A (No GAAP EPS) 0%
Lockheed Martin (NYSE: LMT) $110B $67.6B 14.3x 2.8%
Boeing (NYSE: BA) $130B $66.2B 28.1x 0%
Raytheon Technologies (NYSE: RTX) $140B $67.5B 15.7x 2.3%

The Path Forward: Valuation Realities and Investor Caution

While the $1.75 trillion figure captures headlines, it remains unverified by public filings and may reflect secondary market pricing rather than an IPO prospectus. SpaceX has historically resisted external pressure to move public, with CEO Elon Musk stating in a 2023 interview that the company would remain private until Starship achieves regular, reliable flight—potentially delaying an IPO beyond 2026. Until then, investors seeking exposure must rely on analogous equities or private market funds with limited liquidity.

The broader implication is clear: capital markets are assigning premium valuations to companies that control access to orbit, regardless of near-term profitability. This trend risks creating a valuation bubble in space-related equities if revenue growth fails to meet expectations, particularly as global defense budgets face scrutiny and satellite broadband competition intensifies from players like AST SpaceMobile (NASDAQ: ASTS) and OneWeb.

*Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.*

Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

WHO Approves First Malaria Treatment for Newborns and Infants: Prequalification Milestone for Coartem Baby and Preventive Drug

I Took It to Heart: A Program Inspired by the Music of Kinder, Gentler Times

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.